Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization EBIAT Leases Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In Process Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding

Summit Therapeutics (SMMT) Long-Term Debt Issuances (2021 - 2022)

Summit Therapeutics' Long-Term Debt Issuances history spans 2 years, with the latest figure at $520.0 million for Q4 2022.

For Q4 2022, Long-Term Debt Issuances changed N/A year-over-year to $520.0 million; the TTM value through Sep 2023 reached $520.0 million, up 1980.0%, while the annual FY2022 figure was $545.0 million, 395.45% up from the prior year.
Long-Term Debt Issuances reached $520.0 million in Q4 2022 per SMMT's latest filing, up from $25.0 million in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $520.0 million in Q4 2022 to a low of $25.0 million in Q1 2022.